Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zogenix Inc (NASDAQ:ZGNX)

10.25
Delayed Data
As of Apr 29
 -0.38 / -3.57%
Today’s Change
7.90
Today|||52-Week Range
21.65
-30.46%
Year-to-Date
No recent news for Zogenix Inc.

Today’s Trading

Previous close10.63
Today’s open10.65
Day’s range10.15 - 10.81
Volume75,335
Average volume (3 months)268,079
Market cap$253.9M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-578.65%
Earnings growth (this year)-327.54%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-31.70%
P/E ratioNM
Price/Sales11.42
Price/Book1.39

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc-0.42-5.36%
BITIBiotie Therapies Cor...+0.07+0.26%
GALEGalena Biopharma Inc-0.05-3.50%
ARLZAralez Pharmaceutica...-0.19-4.63%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 9, 2016
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$27.7M
Annual profit (last year)-$49.3M
Net profit margin-150.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Stephen J. Farr
CFO, Secretary, Treasurer &
Executive VP
Ann D. Rhoads
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs